Comparison of Clinical Outcomes Following Acute Myocardial Infarctions in Hypertensive Patients With or Without Diabetes

Background and Objectives It is thought that patients with diabetes mellitus (DM) have a poor prognosis after an acute myocardial infarction (AMI), but the effect of diabetes on the outcomes of hypertensive patients with AMIs has not been elucidated in the Korean population. The aim of this study was to investigate the effects of diabetes on long-term clinical outcomes following AMIs in patients with hypertension. Subjects and Methods Using data from the Korea Acute Myocardial Infarction Registry (November 2005 to December 2006), 2,233 hypertensive patients with AMIs were grouped as follows based on the presence of DM: group I, diabetic hypertension (n=892, 544 men, mean age=66.2±10.9 years); and group II, non-diabetic hypertension (n=1341, 938 men, mean age=63.9±12.8 years). The primary study outcomes included in-hospital death and major adverse cardiac events (MACE; cardiac death, myocardial infarction (MI), repeat percutaneous coronary intervention, and coronary artery bypass surgery) at the 1 year follow-up. Results Hypertensive patients with DM were older and more likely to be women. The diabetic group had lower blood pressure (p<0.001), a lower left ventricular ejection fraction (p<0.001), a more severe degree of heart failure (p<0.001), a longer duration of coronary care unit admission (p<0.001), and a higher incidence of hyperlipidemia (p=0.007). The N-terminal pro-brain natriuretic peptide level (4602.5±8710.6 pg/mL vs. 2320.8±5837.9 pg/mL, p<0.001) was higher and the creatinine clearance (62.4±29.9 mL/min vs. 73.0±40.8 mL/min, p<0.001) was lower in the diabetic group than the non-diabetic group. Coronary angiographic findings revealed more frequent involvement of the left main stem (p=0.002) and multiple vessels (p<0.001) in the diabetic group. The rate of in-hospital death was higher in the diabetic group (p<0.001). During follow-up, the rates of composite MACE at 1 month, 6 months, and 12 months were higher in the diabetic group (p<0.001). Conclusion In hypertensive patients with AMI, DM was associated with worse clinical and angiographic features, with a higher risk of development of severe heart failure, and an increased risk of MACE on long-term clinical follow-up.

[1]  M. Jeong,et al.  N-terminal pro-B-type natriuretic peptide is associated with adverse short-term clinical outcomes in patients with acute ST-elevation myocardial infarction underwent primary percutaneous coronary intervention. , 2009, International journal of cardiology.

[2]  J. Cho,et al.  Gender differences of success rate of percutaneous coronary intervention and short term cardiac events in Korea Acute Myocardial Infarction Registry. , 2008, International journal of cardiology.

[3]  Michael M. Engelgau,et al.  Prevalence of Diabetes and Impaired Fasting Glucose in Adults in the U.S. Population , 2006, Diabetes Care.

[4]  Tae Ik Kim,et al.  Isolated and Combined Influences of Diabetes and Hypertension on the Myocardial Function and Geometry , 2006 .

[5]  L. Tavazzi,et al.  Metabolic syndrome and risk of cardiovascular events after myocardial infarction. , 2005, Journal of the American College of Cardiology.

[6]  J. Gore,et al.  Implications of diabetes in patients with acute coronary syndromes. The Global Registry of Acute Coronary Events. , 2004, Archives of internal medicine.

[7]  Michele Muggeo,et al.  Population-based incidence rates and risk factors for type 2 diabetes in white individuals: the Bruneck study. , 2004, Diabetes.

[8]  S. Saydah,et al.  Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. , 2004, JAMA.

[9]  V. Boyko,et al.  Hospital and 1-year outcome after acute myocardial infarction in patients with diabetes mellitus and hypertension , 2003, Journal of Human Hypertension.

[10]  B. Cha,et al.  Metabolic Syndrome and Cardiovascular Disease , 2003 .

[11]  L. Hsu,et al.  Clinical outcomes of patients with diabetes mellitus and acute myocardial infarction treated with primary angioplasty or fibrinolysis , 2002, Heart.

[12]  Á. Avezum,et al.  Practice variation and missed opportunities for reperfusion in ST-segment-elevation myocardial infarction: findings from the Global Registry of Acute Coronary Events (GRACE) , 2002, The Lancet.

[13]  E. Frohlich,et al.  Diabetes, Hypertension, and Cardiovascular Disease: An Update , 2001, Hypertension.

[14]  D S Bell,et al.  Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus. , 2000, New England Journal of Medicine.

[15]  John S Yudkin,et al.  Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study , 2000, BMJ : British Medical Journal.

[16]  A. Melgarejo-Moreno,et al.  Prognostic significance of diabetes in acute myocardial infarction. Are the differences linked to female gender? , 1999, International journal of cardiology.

[17]  S. Kiechl,et al.  Prevalence of insulin resistance in metabolic disorders: the Bruneck Study. , 1998, Diabetes.

[18]  R. Califf,et al.  Influence of Diabetes Mellitus on Clinical Outcome in the Thrombolytic Era of Acute Myocardial Infarction , 1997 .

[19]  U. Goldbourt,et al.  Ten-year survival after acute myocardial infarction: Comparison of patients with and without diabetes , 1997 .

[20]  J. Chesebro,et al.  Mechanisms Determining Course and Outcome of Diabetic Patients Who Have Had Acute Myocardial Infarction , 1997, Annals of Internal Medicine.

[21]  Hyun Chul Lee,et al.  Insulin Resistance as an Associated Factor of Essential Hypertension in Korean , 1996 .

[22]  E. Grossman,et al.  Diabetic and Hypertensive Heart Disease , 1996, Annals of Internal Medicine.

[23]  A. Maggioni,et al.  Prognostic value of a history of hypertension in 11483 patients with acute myocardial infarction treated with thrombolysis , 1996 .

[24]  J Col,et al.  Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction. Results from an international trial of 41,021 patients. GUSTO-I Investigators. , 1995, Circulation.

[25]  Lippincott Williams Wilkins,et al.  National High Blood Pressure Education Program Working Group Report on Hypertension in Diabetes , 1994, Hypertension.

[26]  A. Melis,et al.  Insulin hypersecretion: a distinctive feature between essential and secondary hypertension. , 1992, Metabolism: clinical and experimental.

[27]  L. Rydén,et al.  Myocardial infarction in patients with diabetes mellitus. , 1988, European heart journal.

[28]  Marie Clark What is diabetes? , 1982, British medical journal.

[29]  J. Herlitz,et al.  Five-year prognosis after acute myocardial infarction in relation to a history of hypertension. , 1996, American journal of hypertension.

[30]  W. Reeves,et al.  Alteration of coronary perfusion reserve in hypertensive patients with diabetes. , 1994, Journal of human hypertension.